secwatch.observer — SEC 8-K summary
======================================

Issuer:     CRYO CELL INTERNATIONAL INC (CCEL)
CIK:        0000862692
Form:       8-K
Filed at:   2022-02-24T23:59:59+00:00
Accession:  0000950170-22-002003
Event type: earnings
Sentiment:  negative
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cryo-Cell reports FY2021 revenue $28.9M (-7% YoY), net income $2.1M (-42% YoY)
------------------------------------------------------------------------------

- Revenue $28.9M, down 7% from $31.1M; processing/storage fees $28.4M vs $29.5M.
- Net income $2.1M ($0.26 basic EPS) vs $3.6M ($0.48 basic EPS) in FY2020.
- Public banking revenue fell to $376K from $727K; no licensee income vs $630K prior year.
- Recorded $1.2M public bank inventory impairment and $782K gain on contingent consideration.
- SG&A increased 2% while cost of sales decreased 7% YoY.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/862692/000095017022002003/0000950170-22-002003-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/862692/000095017022002003/ccel-20220222.htm
  HTML page:      https://secwatch.observer/filing/0000950170-22-002003

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer